Death of a Drug takes place in 1996. Inhaber-Taft was one of the top global pharmaceutical companies, with a long history of scientific breakthroughs in the treatment of diseases. The corporation s top-notch marketing and sales division turned these chemical compounds into blockbuster drugs. But the ethical, albeit stodgy culture begins to change when a valid post-marketing clinical trial, conducted with the drug MELAVOX, reveals the highest dose of the drug causes heart attacks and stroke. This presents a challenge to both the sales force and the marketing team who had boastfully informed...